Thursday, February 10, 2022 3:04:57 PM
My concern is that BLDV will resolve its issues with the DTC and be free to do a RS. That would hurt the stockholders in the long run. Secondly the preferred shares can be converted into approx 2 billion common. Even if the company doesn't do a RS, if the preferred shares are converted then you will have almost 7 billion shares outstanding.
At that point the chances of up-listing get considerably more difficult without a RS.
Remember Josh has already tried to do a RS; there's no reason to think he would not try again if the DTC lets him.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM